1. Home
  2. DAWN vs CTOS Comparison

DAWN vs CTOS Comparison

Compare DAWN & CTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAWN
  • CTOS
  • Stock Information
  • Founded
  • DAWN 2018
  • CTOS 1988
  • Country
  • DAWN United States
  • CTOS United States
  • Employees
  • DAWN N/A
  • CTOS N/A
  • Industry
  • DAWN Biotechnology: Pharmaceutical Preparations
  • CTOS Diversified Commercial Services
  • Sector
  • DAWN Health Care
  • CTOS Consumer Discretionary
  • Exchange
  • DAWN Nasdaq
  • CTOS Nasdaq
  • Market Cap
  • DAWN 1.3B
  • CTOS 1.1B
  • IPO Year
  • DAWN 2021
  • CTOS N/A
  • Fundamental
  • Price
  • DAWN $12.15
  • CTOS $5.12
  • Analyst Decision
  • DAWN Strong Buy
  • CTOS Buy
  • Analyst Count
  • DAWN 7
  • CTOS 5
  • Target Price
  • DAWN $36.33
  • CTOS $6.90
  • AVG Volume (30 Days)
  • DAWN 1.1M
  • CTOS 978.7K
  • Earning Date
  • DAWN 02-24-2025
  • CTOS 03-06-2025
  • Dividend Yield
  • DAWN N/A
  • CTOS N/A
  • EPS Growth
  • DAWN N/A
  • CTOS N/A
  • EPS
  • DAWN N/A
  • CTOS N/A
  • Revenue
  • DAWN $101,953,000.00
  • CTOS $1,803,294,000.00
  • Revenue This Year
  • DAWN N/A
  • CTOS N/A
  • Revenue Next Year
  • DAWN $34.82
  • CTOS $1.99
  • P/E Ratio
  • DAWN N/A
  • CTOS N/A
  • Revenue Growth
  • DAWN N/A
  • CTOS N/A
  • 52 Week Low
  • DAWN $11.13
  • CTOS $3.03
  • 52 Week High
  • DAWN $18.07
  • CTOS $7.00
  • Technical
  • Relative Strength Index (RSI)
  • DAWN 44.59
  • CTOS 44.57
  • Support Level
  • DAWN $11.93
  • CTOS $5.02
  • Resistance Level
  • DAWN $13.53
  • CTOS $5.40
  • Average True Range (ATR)
  • DAWN 0.56
  • CTOS 0.23
  • MACD
  • DAWN 0.03
  • CTOS 0.02
  • Stochastic Oscillator
  • DAWN 35.21
  • CTOS 31.28

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

About CTOS Custom Truck One Source Inc.

Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.

Share on Social Networks: